focus, common objectives and a high level of trust & transparency.
Vatche founded Vantage BioTrials Inc in 2007. Prior to taking on this new venture, he was an independent clinical research consultant working for big pharma. He also held several management positions with companies such as Pfizer Canada and Covance, as well as senior level CRA positions with PPD, CroMedica/PRA International, LAB Pharmaceutical Research, and Phoenix International Life Sciences/MDS Pharma. He has been involved in the pharmaceutical industry for over 15 years and has gained broad experience handling complicated clinical trials across a vast array of therapeutic areas, specializing in clinical operations, project management and clinical monitoring. Vatche holds a Bachelor’s of Science in Biochemistry and a Master’s in Administration from Concordia University. He has also been awarded several prestigious recognitions such as “2011 Emerging Pharmaceutical Leader Award” by PharmExec Magazine, Strathmore’s “Outstanding Pharmaceutical Professional” award, and recognized as a Prestigious Member of Stanford’s Who’s Who. Vatche is also Chairperson of the Montreal Chapter of the Clinical Research Association of Canada and continuously remains involved in the field of clinical research. He is also a prolific speaker and is often invited to speak at pharmaceutical symposiums such as PEX Summit, MAGI Clinical Research, BioConnect, etc. and thoroughly enjoys sharing his experiences and knowledge with his peers.
Vice President, Quality Management
Since joining the CRO industry in 1993, Vahe continues to contribute his valuable knowledge of the clinical trials management process through his broad expertise in GCP/GLP practices and procedures. Before joining Vantage BioTrials in 2007, Vahé held a variety of positions at Phoenix International Life Sciences / MDS Pharma Services of increasing responsibility in clinical monitoring and auditing, compliance and quality management. Since Vantage BioTrials’ inception in 2007, Vahe has played an integral role in introducing and implementing a “Risk Based Approach” to Clinical Trial Management (and specifically clinical monitoring). His dedication to quality remains paramount to the continued satisfaction of Vantage BioTrials’ clients and our continued success.
Vice President, Corporate Development
Viken’s career first began within the industry when he joined Phoenix International Life Sciences in 1995. He then occupied Project Management and Business Development positions at LAB Pharmacological Research, MDS Pharma Services and Allied Research International. Since 2007, Viken’s responsibilities at Vantage BioTrials encompasses global Business Development, General Management and Marketing activities which include, but are not limited to, forecasting, planning, maintaining & securing existing portfolios and new business opportunities, as well as developing & continuously implementing an integrated strategic marketing plan. He constantly plays an integral role in the growth and evolution of Vantage BioTrials as a leading CRO in Canada, as he brings new ideas to the table for continuous innovation in the conduct of clinical trials.